Sumitomo Mitsui DS Asset Management Company Ltd lowered its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Free Report) by 73.0% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 18,354 shares of the pharmacy operator’s stock after selling 49,718 shares during the period. Sumitomo Mitsui DS Asset Management Company Ltd’s holdings in Walgreens Boots Alliance were worth $211,000 at the end of the most recent quarter.
Other institutional investors have also recently made changes to their positions in the company. Townsquare Capital LLC increased its position in shares of Walgreens Boots Alliance by 2.3% during the first quarter. Townsquare Capital LLC now owns 44,104 shares of the pharmacy operator’s stock worth $493,000 after purchasing an additional 996 shares in the last quarter. Central Pacific Bank Trust Division increased its position in shares of Walgreens Boots Alliance by 28.6% during the first quarter. Central Pacific Bank Trust Division now owns 4,500 shares of the pharmacy operator’s stock worth $50,000 after purchasing an additional 1,000 shares in the last quarter. MAI Capital Management increased its position in shares of Walgreens Boots Alliance by 1.9% during the first quarter. MAI Capital Management now owns 57,827 shares of the pharmacy operator’s stock worth $646,000 after purchasing an additional 1,055 shares in the last quarter. Frank Rimerman Advisors LLC increased its position in shares of Walgreens Boots Alliance by 6.6% during the first quarter. Frank Rimerman Advisors LLC now owns 17,682 shares of the pharmacy operator’s stock worth $198,000 after purchasing an additional 1,094 shares in the last quarter. Finally, Independent Advisor Alliance increased its position in shares of Walgreens Boots Alliance by 3.0% during the first quarter. Independent Advisor Alliance now owns 39,978 shares of the pharmacy operator’s stock worth $447,000 after purchasing an additional 1,150 shares in the last quarter. Hedge funds and other institutional investors own 58.59% of the company’s stock.
Analysts Set New Price Targets
Several analysts recently commented on the company. UBS Group reiterated a “neutral” rating on shares of Walgreens Boots Alliance in a research report on Thursday, June 26th. Morgan Stanley reiterated an “underweight” rating on shares of Walgreens Boots Alliance in a research report on Thursday, June 26th. One equities research analyst has rated the stock with a Buy rating, six have assigned a Hold rating and four have assigned a Sell rating to the stock. According to data from MarketBeat.com, Walgreens Boots Alliance presently has a consensus rating of “Reduce” and a consensus target price of $10.15.
Walgreens Boots Alliance Price Performance
Shares of NASDAQ:WBA opened at $11.98 on Tuesday. The company has a quick ratio of 0.32, a current ratio of 0.60 and a debt-to-equity ratio of 0.96. The business has a fifty day moving average of $11.85 and a two-hundred day moving average of $11.41. The stock has a market cap of $10.37 billion, a P/E ratio of -1.64, a PEG ratio of 1.42 and a beta of 0.80. Walgreens Boots Alliance, Inc. has a 52-week low of $8.08 and a 52-week high of $13.25.
Walgreens Boots Alliance (NASDAQ:WBA – Get Free Report) last issued its earnings results on Thursday, June 26th. The pharmacy operator reported $0.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.34 by $0.04. The company had revenue of $38.99 billion during the quarter, compared to analysts’ expectations of $36.72 billion. Walgreens Boots Alliance had a positive return on equity of 17.66% and a negative net margin of 4.07%.The firm’s quarterly revenue was up 7.2% on a year-over-year basis. During the same period in the prior year, the business earned $0.63 EPS. On average, research analysts expect that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
Featured Articles
- Five stocks we like better than Walgreens Boots Alliance
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- How The Weak Dollar Is Fueling These Global Stock Surges
- What is Insider Trading? What You Can Learn from Insider Trading
- 3 Recession-Ready Stocks That Thrive When the Economy Sputters
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- 3 Automation-Focused Stocks Flying Under the Radar
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Free Report).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.